Evaluation of aflibercept and ziv-aflibercept binding affinity to vascular endothelial growth factor, stability and sterility after compounding
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2056-9920
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Evaluation of aflibercept and ziv-aflibercept binding affinity to vascular endothelial growth factor, stability and sterility after compounding ; volume:4 ; number:1 ; day:24 ; month:10 ; year:2018 ; pages:1-7 ; date:12.2018
International Journal of Retina and Vitreous ; 4, Heft 1 (24.10.2018), 1-7, 12.2018
- Creator
-
Lima Farah, Julia de
- Contributor
-
Sano, Ronaldo
Maugéri, Ieda Maria Longo
Teixeira, Daniela
Ishimura, Mayari Eika
Martins, Gabriela
Mimica, Lycia M. J.
Silva, Cely Barreto da
Meyer, Carsten H.
de Oliveira Dias, João Rafael
Andrade, Gabriel Costa de
Farah, Michel Eid
SpringerLink (Online service)
- DOI
-
10.1186/s40942-018-0143-x
- URN
-
urn:nbn:de:101:1-2018112520224700891571
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lima Farah, Julia de
- Sano, Ronaldo
- Maugéri, Ieda Maria Longo
- Teixeira, Daniela
- Ishimura, Mayari Eika
- Martins, Gabriela
- Mimica, Lycia M. J.
- Silva, Cely Barreto da
- Meyer, Carsten H.
- de Oliveira Dias, João Rafael
- Andrade, Gabriel Costa de
- Farah, Michel Eid
- SpringerLink (Online service)
Other Objects (12)
Intravitreal ziv-aflibercept in diabetic vitreous hemorrhage
Pilot study of ziv-aflibercept in myopic choroidal neovascularisation patients
Aflibercept : Therapie der neovaskulären AMD mit Aflibercept: Fallbeispiele und Erfahrungsberichte
Switching to ziv-aflibercept in resistant diabetic macular edema non responsive to ranibizumab injection
Ziv-aflibercept plus pembrolizumab in patients with advanced melanoma resistant to anti-PD-1 treatment
Analytical and Functional Similarity of Aflibercept Biosimilar ABP 938 with Aflibercept Reference Product
Aflibercept : ein innovatives antiangiogenes Wirkprinzip
Aflibercept (Addendum zum Auftrag A14-32)
Aflibercept monotherapy versus aflibercept with targeted retinal laser to peripheral retinal ischemia for diabetic macular oedema (LADAMO)
Aflibercept (Eylea): Nutzenbewertung gemäß § 35a SGB V
Aflibercept (Zaltrap): Nutzenbewertung gemäß § 35a SGB V
Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy
Intravitreal ziv-aflibercept in diabetic vitreous hemorrhage
Pilot study of ziv-aflibercept in myopic choroidal neovascularisation patients
Aflibercept : Therapie der neovaskulären AMD mit Aflibercept: Fallbeispiele und Erfahrungsberichte
Switching to ziv-aflibercept in resistant diabetic macular edema non responsive to ranibizumab injection
Ziv-aflibercept plus pembrolizumab in patients with advanced melanoma resistant to anti-PD-1 treatment
Analytical and Functional Similarity of Aflibercept Biosimilar ABP 938 with Aflibercept Reference Product
Aflibercept : ein innovatives antiangiogenes Wirkprinzip
Aflibercept (Addendum zum Auftrag A14-32)
Aflibercept monotherapy versus aflibercept with targeted retinal laser to peripheral retinal ischemia for diabetic macular oedema (LADAMO)
Aflibercept (Eylea): Nutzenbewertung gemäß § 35a SGB V
Aflibercept (Zaltrap): Nutzenbewertung gemäß § 35a SGB V
Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy
Intravitreal ziv-aflibercept in diabetic vitreous hemorrhage
Pilot study of ziv-aflibercept in myopic choroidal neovascularisation patients
Aflibercept : Therapie der neovaskulären AMD mit Aflibercept: Fallbeispiele und Erfahrungsberichte
Switching to ziv-aflibercept in resistant diabetic macular edema non responsive to ranibizumab injection
Ziv-aflibercept plus pembrolizumab in patients with advanced melanoma resistant to anti-PD-1 treatment
Analytical and Functional Similarity of Aflibercept Biosimilar ABP 938 with Aflibercept Reference Product
Aflibercept : ein innovatives antiangiogenes Wirkprinzip
Aflibercept (Addendum zum Auftrag A14-32)
Aflibercept monotherapy versus aflibercept with targeted retinal laser to peripheral retinal ischemia for diabetic macular oedema (LADAMO)
Aflibercept (Eylea): Nutzenbewertung gemäß § 35a SGB V
Aflibercept (Zaltrap): Nutzenbewertung gemäß § 35a SGB V